Short Summary
Amazon seeks PTAB Director Review of several IPRs against Audio Pod’s patent; the owner must respond within five days without new evidence.
Detailed Summary
In a Director Review Request email dated September 19, 2025, Amazon’s counsel notified the PTAB that the petitioner has filed Director Review requests for six IPRs (IPR2025‑00757, ‑00765, ‑00768, ‑00769, ‑00774, and ‑00777) concerning Audio Pod IP’s U.S. Patent No. 10,091,266. The patent owner is authorized to submit a concise response limited to the issues raised, no longer than 15 pages, and must do so within five business days using the P‑TACTS system. No new evidence may be introduced, and the Board will determine whether to grant the review, affecting the pending challenges to the patent’s claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Amazon.com, Inc. et al. vs Audio Pod IP, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mito Red Light, Inc.vsJoovv, Inc.
Mito Red Light and Joovv have settled their IPR dispute over patent 11253719, filing a joint motion to terminate the proceeding.
American Airlines, Inc. et al.vsIntellectual Ventures I LLC
American Airlines and Southwest Airlines failed to invalidate Intellectual Ventures I LLC's patent covering virtual community networks and IP routing. The PTAB denied the petition, finding that the petitioner could not persuasively demonstrate obviousness over prior art references like Caronni-I and RFC-1383.
Microsoft CorporationvsEyesMatch Ltd.
Google LLC successfully convinced the PTAB that all 18 challenged claims of EyesMatch Ltd.'s patent were unpatentable over various combinations of prior art references. The Board adopted a specific construction for 'mirror tracking mode,' which was central to finding obviousness across multiple grounds.
Amgen Inc. et al.vsBristol-Myers Squibb Company
The PTAB notified Amgen and Bristol‑Myers Squibb that Director Review requests have been filed for IPR2025‑00601 and IPR2025‑00602, setting a five‑day deadline for a limited response and prohibiting new evidence.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple’s IPR petition challenges Omni MedSci’s ’484 wearable health‑monitoring patent, asserting that all 23 claims are obvious over a combination of prior‑art references. The petition seeks institution and a finding of unpatentability.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.